Ioannis A Voutsadakis

56PUBLICATIONS
5CO-AUTHORS
Cancer geneticsPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Jul 28, 2026
Epigenetics and DNA Base Substitutions of Epstein-Barr Virus (EBV)-Related Gastric Cancers: Implications for Targeted Therapies.

|Mar 28, 2026
The Regulation of p53 by Ubiquitination and Implications for Therapeutic Targeting in Colorectal Cancer.

Ioannis A Voutsadakis

|Feb 12, 2026
Biomarkers of primary and secondary resistance to cyclin dependent kinases 4 and 6 inhibitors in metastatic estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer: a narrative review.

Athina Stravodimou, Ioannis A Voutsadakis

|Sep 18, 2025
From PIK3CA Mutations to Rational PI3K Inhibition for the Treatment of Colorectal Cancer.

Ioannis A Voutsadakis

|Jul 23, 2025
Development of CDK4/6 Inhibitors in Gastrointestinal Cancers: Biomarkers to Move Forward.

Ioannis A Voutsadakis

|Jul 12, 2025
Clinical and Pathological Features and Survival Outcomes of Breast Cancers with Intermediate ER Expression.

Jonathan Hammond, Nicholas Lambert, Ioannis A Voutsadakis

Pageof 10

Frequent Collaborators

1 joint publications

Melissa Reed

1 joint publications

Aaron Bertolo

1 joint publications

Christopher Rosso

1 joint publications

Nektarios Koufopoulos